Informations:
Erreur:
Mots-clés
- Clinical Trial (792)
- Adverse event (792)
- Concomitant Medication (95)
- Vaccination (78)
- Clinical Trial, Phase III (72)
- Hepatitis B (65)
- Neurology (61)
- Drug-Related Side Effects and Adverse Reactions (54)
- Breast Neoplasms (53)
- Vaccines (51)
- Hepatitis B Vaccines (47)
- Signs and Symptoms (40)
- Clinical Trial, Phase I (40)
- Haemophilus influenzae type b (39)
- Parkinsons Disease (38)
- Laboratories (38)
- Gastroenterology (37)
- Liver (37)
- Vital Signs (34)
- Pharmacokinetics (32)
- Hematology (32)
- Hepatitis A Vaccines (31)
- On-Study Form (29)
- Physical Examination (28)
- Restless Legs Syndrome (27)
- Hepatitis A (26)
- Diabetes Mellitus, Type 2 (22)
- Hypereosinophilic Syndrome (21)
- Pulmonary Disease, Chronic Obstructive (21)
- Drug trial (21)
- Migraine Disorders (20)
- Follow-Up Studies (19)
- Respiratory Insufficiency (18)
- Safety (18)
- Traumatology (18)
- Clinical Trial, Phase IV (18)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (18)
- Multiple Myeloma (18)
- Neisseria meningitidis (18)
- Colorectal Neoplasms (17)
- Classification (17)
- Medical Oncology (17)
- Pulmonary Medicine (16)
- Clinical Trial, Phase II (16)
- Measles-Mumps-Rubella Vaccine (16)
- Gynecology (16)
- Asthma (15)
- Drugs, Investigational (15)
- Malaria Vaccines (15)
- Electrocardiogram (ECG) (15)
- Influenza Vaccines (15)
- Cardiology (14)
- Eligibility Determination (14)
- Child (13)
- End of Study (13)
- Compliance (13)
- Coronary Disease (13)
- Diphtheria-Tetanus-Pertussis Vaccine (12)
- Depressive Disorder (12)
- Leukemia (12)
- Prostatic Neoplasms (11)
- Psychiatry (11)
- Contraceptives, Oral, Combined (11)
- Demography (11)
- Lung Neoplasms (11)
- Medical History Taking (11)
- Medical Records (11)
- Ophthalmology (11)
- Tetanus (10)
- Sumatriptan (10)
- Diagnostic Imaging (10)
- Diphtheria (10)
- Fever (10)
- Parkinson Disease (10)
- Schizophrenia (9)
- Biopsy (9)
- Communicable Diseases (9)
- Urinalysis (8)
- Substance-Related Disorders (8)
- Endpoint Determination (8)
- Alcohol Drinking (8)
- Alzheimer Disease (8)
- Poliomyelitis (7)
- Whooping Cough (7)
- Pneumococcal Vaccines (7)
- Symptom Assessment (7)
- Healthy Volunteers (7)
- Comparative Study (7)
- Diabetes Mellitus (7)
- Drug Therapy (7)
- Glucocorticoids (7)
- Informed Consent (7)
- Internal Medicine (7)
- Liver Diseases (7)
- Pneumonia (6)
- Rotavirus (6)
- Polysomnography (6)
- Brain Neoplasms (6)
- Meningococcal Vaccines (6)
- Receptors, Dopamine D3 (6)
Table des matières
Modèles de données sélectionnés
Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.
792 Résultats de recherche.
Groupes Item: Patient identification, Adverse Events
Groupes Item: Patient identification, TISS, TISS ventilation, Cardiovascular Support, Kidney supportive measures, Neurologic, Specific intervention, Adverse Events Day 84 to 90, Serious adverse event 84 to 90, Other
Groupes Item: Patient identification, TISS, TISS ventilation, Cardiovascular Support, Kidney supportive measures, Neurologic, Specific intervention, Adverse Events Day 77 to 83, Serious adverse event 77 to 83, Other
Groupes Item: Patient identification, TISS, TISS ventilation, Cardiovascular Support, Kidney supportive measures, Neurologic, Specific intervention, Adverse Events Day 70 to 76, Serious adverse event 70 to 76, Other
Groupes Item: Patient identification, TISS, TISS ventilation, Cardiovascular Support, Kidney supportive measures, Neurologic, Specific intervention, Adverse Events Day 63 to 69, Serious adverse event 63 to 69, Other
Groupes Item: Patient identification, TISS, TISS ventilation, Cardiovascular Support, Kidney supportive measures, Neurologic, Specific intervention, Adverse Events Day 49 to 55, Serious adverse event 49 to 55, Other
Groupes Item: Patient identification, TISS, TISS ventilation, Cardiovascular Support, Kidney supportive measures, Neurologic, Specific intervention, Adverse Events Day 42 to 48, Serious adverse event 42 to 48, Other
Groupes Item: Patient identification, TISS, TISS ventilation, Cardiovascular Support, Kidney supportive measures, Neurologic, Specific intervention, Adverse Events Day 56 to 62, Serious adverse event 56 to 62, Other
Groupes Item: Patient identification, TISS, TISS ventilation, Cardiovascular Support, Kidney supportive measures, Neurologic, Specific intervention, Adverse Events Day 35 to 41, Serious adverse event 35 to 41, Other
Groupes Item: Patient identification, TISS, TISS ventilation, Cardiovascular Support, Kidney supportive measures, Neurologic, Specific intervention, Adverse Events Day 17 to 20, Serious adverse event Day 17 to 20, Other
Groupes Item: Patient identification, TISS, TISS ventilation, Cardiovascular Support, Kidney supportive measures, Neurologic, Specific intervention, Adverse Events Day 21 to 24, Serious adverse event 21 to 24, Other
Groupes Item: Patient identification, TISS, TISS ventilation, Cardiovascular Support, Kidney supportive measures, Neurologic, Specific intervention, Adverse Events Day 13 to 16, Serious adverse event Day 13 to 16, Other